Abbott Laboratories

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0028241000
USD
125.40
0.11 (0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
41,950.00
40,109.00
43,653.00
43,075.00
34,608.00
31,904.00
30,578.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
41,950.00
40,109.00
43,653.00
43,075.00
34,608.00
31,904.00
30,578.00
Raw Material Cost
20,625.00
20,072.00
21,330.00
19,861.00
17,231.00
15,211.00
14,755.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
603.00
698.00
315.00
410.00
708.00
818.00
729.00
Selling and Distribution Expenses
11,651.00
10,883.00
11,109.00
11,276.00
9,668.00
9,694.00
9,691.00
Other Expenses
222.00
202.10
253.70
232.80
171.00
159.00
155.90
Total Expenditure (Excl Depreciation)
35,099.00
33,674.00
35,291.00
33,875.00
29,317.00
27,313.00
26,734.00
Operating Profit (PBDIT) excl Other Income
6851
6435
8362
9200
5291
4591
3844
Other Income
763.00
1,115.00
468.00
-56.00
536.00
505.00
5.00
Operating Profit (PBDIT)
10,832.00
10,793.00
12,097.00
12,682.00
9,154.00
8,110.00
7,127.00
Interest
603.00
698.00
315.00
410.00
708.00
818.00
729.00
Exceptional Items
2.00
-188.00
-209.00
-523.00
-151.00
-201.00
-247.00
Gross Profit (PBDT)
21,325.00
20,037.00
22,323.00
23,214.00
17,377.00
16,693.00
15,823.00
Depreciation
3,218.00
3,243.00
3,267.00
3,538.00
3,327.00
3,014.00
3,278.00
Profit Before Tax
7,013.00
6,664.00
8,306.00
8,211.00
4,968.00
4,077.00
2,873.00
Tax
-6,389.00
941.00
1,373.00
1,140.00
497.00
390.00
539.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13,351.00
5,701.00
6,905.00
7,042.00
4,449.00
3,666.00
2,319.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13,351.00
5,701.00
6,905.00
7,042.00
4,449.00
3,666.00
2,319.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13,351.00
5,701.00
6,905.00
7,042.00
4,449.00
3,666.00
2,319.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
47,664.00
38,603.00
36,686.00
35,802.00
32,784.00
31,088.00
30,524.00
Earnings per share (EPS)
7.64
3.26
3.91
3.94
2.5
2.06
1.33
Diluted Earnings per share
7.64
3.26
3.91
3.94
2.5
2.06
1.33
Operating Profit Margin (Excl OI)
16.33%
16.04%
19.16%
21.36%
15.29%
14.39%
12.57%
Gross Profit Margin
24.39%
24.7%
26.51%
27.28%
23.97%
22.23%
20.12%
PAT Margin
31.83%
14.21%
15.82%
16.35%
12.86%
11.49%
7.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 4.59% vs -8.12% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 134.19% vs -17.44% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 4.04% vs -16.78% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -13.61% vs 121.59% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Abbott Laboratories With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
41,950.00
42,879.00
-929.00
-2.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
41,950.00
42,879.00
-929.00
-2.17%
Raw Material Cost
20,625.00
25,151.00
-4,526.00
-18.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
603.00
1,654.00
-1,051.00
-63.54%
Selling and Distribution Expenses
11,651.00
8,676.00
2,975.00
34.29%
Other Expenses
222.00
-26.40
248.40
940.91%
Total Expenditure (Excl Depreciation)
35,099.00
35,217.00
-118.00
-0.34%
Operating Profit (PBDIT) excl Other Income
6,851.00
7,662.00
-811.00
-10.58%
Other Income
763.00
1,103.00
-340.00
-30.83%
Operating Profit (PBDIT)
10,832.00
11,873.00
-1,041.00
-8.77%
Interest
603.00
1,654.00
-1,051.00
-63.54%
Exceptional Items
2.00
-73.00
75.00
102.74%
Gross Profit (PBDT)
21,325.00
17,728.00
3,597.00
20.29%
Depreciation
3,218.00
3,108.00
110.00
3.54%
Profit Before Tax
7,013.00
7,037.00
-24.00
-0.34%
Tax
-6,389.00
657.00
-7,046.00
-1,072.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
13,351.00
6,335.00
7,016.00
110.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13,351.00
6,335.00
7,016.00
110.75%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
3.00
-3.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13,351.00
6,338.00
7,013.00
110.65%
Equity Capital
0
0
0.00
Face Value
0.00
1.00
0.00
Reserves
47,664.00
49,584.00
-1,920.00
-3.87%
Earnings per share (EPS)
7.64
16.54
-8.90
-53.81%
Diluted Earnings per share
7.64
16.54
-8.90
-53.81%
Operating Profit Margin (Excl OI)
16.33%
17.87%
0.00
-1.54%
Gross Profit Margin
24.39%
23.66%
0.00
0.73%
PAT Margin
31.83%
14.77%
0.00
17.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 4,195.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.59% vs -8.12% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 1,335.10 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 134.19% vs -17.44% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,006.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.04% vs -16.78% in Dec 2023

Annual - Interest
Interest 60.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -13.61% vs 121.59% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.33%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023